Also available in Persian — نسخه فارسی EN فا
❓ Unknown

FDA Approvals Post-21st Century Cures Act: Fewer Studies Required

2w ago August 27, 2026 1 min read 📰 Medical Xpress
📋 Key Takeaway

Since the 21st Century Cures Act was enacted in 2016, FDA approvals for new medical products have increasingly depended on fewer studies, as highlighted by a recent study from U.S. researchers. This trend raises concerns about the rigor of medical product evaluations. For Iran, this could impact the availability and safety of medical products in the market.

🔍 Quick Context Guide
💡 Bottom Line: The FDA's shift towards fewer studies for product approvals raises significant safety concerns that could impact healthcare in Iran and beyond.

👥 Key Players

FDA (Food and Drug Administration) MENTIONED
Regulatory body for medical products in the U.S.
"The FDA's approval processes directly influence the availability and safety of medical products, which is crucial for Iran's healthcare system."
21st Century Cures Act MENTIONED
Legislation aimed at accelerating medical product development.
"This act has significant implications for how medical products are evaluated and approved, affecting global standards including those in Iran."
Stanford University School of Medicine MENTIONED
Research institution involved in the study.
"Their research findings can influence perceptions and policies regarding medical product safety and efficacy worldwide."

📰 What Happened

A recent study indicates that since the 21st Century Cures Act was enacted in 2016, the FDA has been approving new medical products with fewer studies required for evaluation. This trend raises concerns about the thoroughness of product assessments.

  • The FDA's approval process has become less rigorous since 2016.
  • Concerns have been raised regarding the safety and efficacy of medical products as a result.

💡 Why It Matters

🇮🇷 For Iran: The trend of fewer studies required for FDA approvals could lead to the introduction of less rigorously tested medical products in Iran, affecting public health.
🌍 Regional: If similar practices are adopted in the region, it could compromise healthcare standards across the Middle East.
🌐 International: Internationally, this could lead to a decline in trust in U.S. medical products and influence global regulatory practices.

📚 Background

The 21st Century Cures Act was designed to expedite the development of new medical treatments, but its implementation has led to debates about the balance between speed and safety in medical product approvals.

Pharmaceutical regulation Global health standards
📡 Source: NEUTRAL
📊 Confidence: 70%
The study is published in a peer-reviewed journal, suggesting a level of credibility, but interpretations may vary based on the source's perspective.

Since the passage of the 21st Century Cures Act in 2016, Food and Drug Administration (FDA) approvals for new medical products have relied on fewer studies, according to a study published Aug. 26, 2026, in the PLOS ONE by researchers from the Stanford University School of Medicine Clinical Excellence Research Center, Oregon State University and UCLA, U.S.

🌐

Translated from the original and edited for English readers. View original source →

Translation confidence: 100%

📰 Related Coverage

⚖️ Independent Platform — Artesh.com is not affiliated with any government, military, or political organization. Editorial Policy →